Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2/3 1Phase 2 1

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 956Neoplasms 755Carcinoma, Non-Small-Cell Lung 742Prostatic Neoplasms 569Colorectal Neoplasms 499Lung Neoplasms 444Neoplasm Metastasis 400Multiple Myeloma 371Leukemia, Myeloid, Acute 351Ovarian Neoplasms 307Pancreatic Neoplasms 301Melanoma 273Squamous Cell Carcinoma of Head and Neck 257Recurrence 248Carcinoma, Hepatocellular 229Glioblastoma 223Brain Neoplasms 219Head and Neck Neoplasms 199Triple Negative Breast Neoplasms 198Carcinoma, Renal Cell 197Precursor Cell Lymphoblastic Leukemia-Lymphoma 190Lymphoma 188Stomach Neoplasms 186Endometrial Neoplasms 177Lymphoma, Non-Hodgkin 172Sarcoma 168Glioma 165Uterine Cervical Neoplasms 160Lymphoma, Large B-Cell, Diffuse 160Hematologic Neoplasms 157

Interventions

Alpelisib 2mirdametinib 1Injections, Intralesional 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Lymphangioma, Cystic × 90 days × Clear all
NCT05948943 2026-06-02

EPIK-L1

Novartis

Phase 2/3 Recruiting
232 enrolled

Lymphangioma, Lymphangioma, Cystic, Lymphatic Abnormalities

NCT05983159 2026-05-05

TARGET-VM

Murdoch Childrens Research Institute

Phase 2 Recruiting
50 enrolled

Arteriovenous Malformations, Lymphangioma, Skin Diseases, Vascular, Lymphangioma, Cystic, Lymphatic Abnormalities, Vascular Malformations

NCT07246928 2026-04-30

US: Ultrasound

Delta University for Science and Technology

Phase NA Completed
1 enrolled

Lymphangioma, Cystic

NCT07189832 2026-04-28

Bleomycin Intralesional Injections of Cystic Hygromas

Delta University for Science and Technology

Phase NA Completed
30 enrolled

Lymphangioma, Cystic, Lymphatic Abnormalities

Data powered by HemOnc (CC BY 4.0) Colophon âš¡